CIIC Fall 2023 Conference
Oct 13 - Oct 14, 2023
- Title: Efficacy and safety of bradykinin B2 receptor antagonism with deucrictibant immediate-release capsule for treatment of hereditary angioedema attacks: results of RAPIDe-1 phase 2 trial
Presenter: Joshua S. Jacobs, M.D.
Date/Time: Saturday, October 14, 2023, 1:30-2:15 p.m. CDT (2:30-3:15 p.m. EDT)
Location: Tate Pre-Function A, Station #1
- Title: Early symptom relief following treatment with the oral bradykinin B2 receptor antagonist deucrictibant immediate-release capsule in patients with hereditary angioedema attacks
Presenter: Michael E. Manning, M.D.
Date/Time: Saturday, October 14, 2023, 1:30-2:15 p.m. CDT (2:30-3:15 p.m. EDT)
Location: Tate Pre-Function A, Station #2